Pravastatin Sodium
Product Images NDC 53217-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 53217-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pravastatin Sodium Tablets, Usp (Pravastatin Usp 1)

FDA Label Image

Pravastatin Sodium Tablets, Usp (Pravastatin Usp 2)

Pravastatin Sodium Tablets, Usp (Pravastatin Usp 2)
The text describes the proportion of subjects who did not experience events related to coronary heart disease death or nonfatal myocardial infarction. It also shows survival distributions and a logrank value of P=0.0001. There is a chart displaying years since randomization and the proportion of subjects over time for placebo and pravastatin treatments.*
FDA Label Image

Image Description (Pravastatin Usp 3)

Image Description (Pravastatin Usp 3)
This is information about Pravastatin, a medication with a strength of 2mg. The package includes 30 tablets and the manufacturer is Cadila Healthcare Ltd. The NDC number is 53217-0203-30, and it is a generic version of Pravaghol or Pravastatin. The package contains white tablets with the imprint "36" on them. Dosage instructions are not provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.